Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05972720 |
|---|---|
| Brief Title: | A Phase 2 Study of CRG-022 in Patients With Relapsed/Refractory Large B-cell Lymphoma |
| First Submitted : | July 25, 2023 |
| First Submitted that Met QC Criteria : | July 25, 2023 |
| First Posted : | August 2, 2023 |
| Last Update Submitted that Met QC Criteria : | May 6, 2024 |
| Last Update Posted : | May 7, 2024 |